P2ry10 inhibitors are a class of chemical compounds that specifically target and inhibit the P2ry10 receptor, a member of the purinergic receptor family, which is part of the G-protein-coupled receptor (GPCR) superfamily. P2ry10 is involved in cellular communication by responding to extracellular lysophospholipids, particularly lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P). These signaling molecules are essential for regulating a variety of cellular processes, including cell migration, proliferation, and intracellular signaling pathways. The P2ry10 receptor mediates its effects by activating intracellular G-proteins, which then initiate downstream signaling cascades that influence cell behavior. Inhibitors of P2ry10 function by preventing these ligands from binding to the receptor, thereby blocking the signaling pathways that are normally activated in response to extracellular signals.
Researchers use P2ry10 inhibitors to study the precise role of this receptor in lysophospholipid signaling and its broader effects on cellular functions. By inhibiting P2ry10, scientists can explore how the disruption of this receptor's activity affects cellular processes such as chemotaxis, cytoskeletal reorganization, and cell-to-cell communication. P2ry10 inhibitors also provide insights into how lysophospholipid signaling integrates with other GPCR-mediated pathways, helping to elucidate the complex network of interactions that regulate cellular responses to environmental stimuli. The study of P2ry10 inhibitors deepens our understanding of the role of lysophospholipid receptors in maintaining cellular organization and signal transduction, offering valuable information about how these pathways contribute to various physiological processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA and inhibits RNA synthesis, potentially impacting the transcription of P2Y receptor family member 10. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis by interfering with translocation, potentially leading to reduced expression of P2Y receptor family member 10 at the translational level. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin causes premature chain termination during protein synthesis, potentially leading to reduced expression of P2Y receptor family member 10 and other proteins. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits protein phosphorylation and may impact the signaling pathways that regulate the expression of P2Y receptor family member 10. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in protein synthesis, potentially impacting the translational regulation of P2Y receptor family member 10. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation of proteins, potentially affecting the folding and trafficking of P2Y receptor family member 10. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil inhibits thymidylate synthase, an enzyme involved in DNA synthesis, potentially impacting the transcription of P2Y receptor family member 10. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin inhibits protein and DNA synthesis, potentially impacting the translational and transcriptional regulation of P2Y receptor family member 10. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib inhibits the proteasome, the cellular complex responsible for degrading proteins, potentially impacting the degradation of P2Y receptor family member 10. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib inhibits the activity of the epidermal growth factor receptor (EGFR), a receptor tyrosine kinase involved in cell signaling, potentially impacting the signaling pathways regulating the expression of P2Y receptor family member 10. | ||||||